Tromboelastography in the evaluation of coagulation disorders in patients with sepsis

Turkish Journal of Medical Sciences

Volumn 44, Issue 2, 2014, Pages 267-272

  Kiliç, Yeliz ^a   Topçu, Ismet ^a   Bambal, Hamza ^a   Çivi, Melek ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Coagulation; Sepsis; Thromboelastography

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOELASTOGRAPHY; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; HEMATOCRIT; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; PROSPECTIVE STUDY; SYSTOLE; THROMBOCYTE COUNT; THROMBOPHILIA;

CALCITONIN; HEMOGLOBIN; OXYGEN; PROCALCITONIN; PROTEIN PRECURSOR;

BLOOD PRESSURE; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INTENSIVE CARE UNITS; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OXYGEN; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN TIME; SEPSIS; SYSTOLE; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 84892417523     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1210-99     Document Type: Article

References (30)

1. Reinhart K, Bloos F, Brunkhorst FM. Pathophysiology of sepsis and multiple organ dysfunction. In Fink M P, Abraham E, Vincent JL, Kochanek PM, editors. Textbook of Critical Care. 5th ed. Philadelphia, PA, USA: Elsevier-Saunders; 2005. pp. 1249-1258.
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
3. Vincent JL. Sepsis: the systemic infammatory response. In Papadakos PJ, Szalados JE, editors. Critical Care - Te Requisites in Anesthesiology. Philadelphia, PA, USA: Elsevier Mosby; 2005. pp. 3-10.
4. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012; 26: 1-13.
5. Topçu I, Çivi M, Öztürk T, Keleş GT, Çoban S, Yentür EA, Okçu G. Evaluation of hemostatic changes using thromboelastography afer crystalloid or colloid fuid administration during major orthopedic surgery. Braz J Med Biol Res 2012; 45: 869-874.
6. Angus DC, Linde-Zwirble W T, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
7. Yildiz BD, Yorganci K. Current trends and future implications in sepsis treatment. Turk J Med Sci 2008; 38: 501-510.
8. Ceylan BG, Yavuz L, Eroǧlu F, Gülmen Ş, Tarhan ÖR, Alaca A. The efects of adjuvant therapies for sepsis on hepatic and renal function: a retrospective analysis of 108 ICU patients. Turk J Med Sci 2010; 40: 949-957.
9. Martin GS, Mannino DM, Eaton S, Moss M. Te epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defnitions Conference. Crit Care Med 2003; 31: 1250-1256.
11. Balk RA. Severe sepsis and septic shock: defnitions, epidemiology, and clinical manifestations. Crit Care Clin 2000; 16: 179-192.
12. Meço BC, Cuhruk FH, Tulunay M, Oral M, Ünal MN. Can plasma free-DNA concentration be a diagnostic tool in critically ill septic patients? Turk J Med Sci 2013; 43: 150-155.
13. Levi M, Schultz M, van der Poll T. Disseminated intravascular coagulation in infectious disease. Semin Tromb Hemost 2010; 36: 367-377.
14. Laterre PF, Levy H, Clermont G, Ball DE, Garg R, Nelson DR, Dhainaut JF, Angus DC. Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial. Crit Care Med 2004; 32: 2207-2218.
15. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF; PROWESS Sepsis Study Group. Universal changes in biomarkers of coagulation and infammation occur in patients with severe sepsis, regardless of causative micro-organism. Critical Care 2004; 8: R82-90.
16. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards defnition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Tromb Haemost 2001; 86: 1327-1330.
17. Harris RL, Musher DM, Bloom K, Gathe J, Rice L, Sugarman B, Williams TW Jr, Young EJ. Manifestation of sepsis. Arch Intern Med 1987; 147: 1895-1906.
18. Mallett S V, Cox DJ. Trombelastography. Br J Anaesth 1992; 69: 307-313.
19. Francis JL, Francis DA, Gunathilagan GJ. Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography. Tromb Res 1994; 74: 335-346.
20. Sivula M, Pettila V, Niemi T T, Varpula M, Kuitunen AH. Tromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009; 20: 419-426.
21. Daudel F, Kessler U, Folly H, Linert JS, Takala J, Jacob SM. Tromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care Med 2009; 13: R42.
22. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of care coagulation devices. Anesth Analg 2008; 106: 1366-1375.
23. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fbrinolysis and coagulation in humans. J Tromb Haemos 2006; 4: 411-416.
24. Collins P W, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135: 220-227.
25. Grant H W, Hadley GP. Prediction of neonatal sepsis by tromboelastography. Pediatr Surg Int 1997; 12: 289-292.
26. Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Størkson R, Hervig T. Tromboelastography. Transfus Apher Sci 2009; 40: 119-123.
27. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients sufering from sepsis. Crit Care 2006; 10: R160.
28. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Tromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100: 1576-1583.
29. Rafq S, Johansson PI, Ostrowski SR, Stissing T, Steinbrüchel DA. Hypercoagulability in patients undergoing coronary artery bypass grafing: prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012; 41: 550-555.
30. Mahla E, Lang T, Vicenzi MN, Werkgartner G, Maier R, Probst C, Metzler H. Tromboelastography for monitoring prolonged hypercoagulability afer major abdominal surgery. Anesth Analg 2001; 92: 572-577.